Daito Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3486150000
JPY
1,305.00
-2 (-0.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'25
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Net Sales
14,034.00
12,025.00
11,906.00
12,678.00
12,233.00
10,552.00
11,932.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,034.00
12,025.00
11,906.00
12,678.00
12,233.00
10,552.00
11,932.00
Raw Material Cost
11,772.00
10,028.00
9,777.00
10,428.00
9,689.00
8,447.00
9,217.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
38.00
34.00
34.00
17.00
19.00
13.00
6.00
Selling and Distribution Expenses
1,510.00
1,600.00
1,507.00
1,400.00
1,132.00
808.00
880.00
Other Expenses
-3.80
-3.40
-3.40
-1.70
60.40
46.90
62.10
Total Expenditure (Excl Depreciation)
13,282.00
11,628.00
11,284.00
11,828.00
11,444.00
9,737.00
10,724.00
Operating Profit (PBDIT) excl Other Income
752
397
622
850
789
815
1208
Other Income
-1.00
37.00
-101.00
558.00
-21.00
324.00
4.00
Operating Profit (PBDIT)
1,875.00
1,539.00
1,582.00
2,450.00
1,828.00
2,041.00
2,079.00
Interest
38.00
34.00
34.00
17.00
19.00
13.00
6.00
Exceptional Items
-164.00
129.00
2.00
0.00
30.00
0.00
15.00
Gross Profit (PBDT)
2,262.00
1,997.00
2,129.00
2,250.00
2,544.00
2,105.00
2,715.00
Depreciation
1,124.00
1,105.00
1,061.00
1,042.00
1,060.00
902.00
867.00
Profit Before Tax
549.00
530.00
487.00
1,392.00
778.00
1,125.00
1,223.00
Tax
-127.00
158.00
247.00
914.00
-130.00
349.00
392.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
691.00
309.00
291.00
617.00
956.00
787.00
868.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
691.00
309.00
291.00
617.00
956.00
787.00
868.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-16.00
63.00
-50.00
-140.00
-48.00
-11.00
-37.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
675.00
372.00
241.00
477.00
908.00
776.00
831.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
52,003.00
51,530.00
52,013.00
52,003.00
52,069.00
51,808.00
51,864.00
Earnings per share (EPS)
22.87
10.16
9.48
20.21
30.82
50.13
27.49
Diluted Earnings per share
22.87
10.16
9.48
20.21
30.82
50.13
27.49
Operating Profit Margin (Excl OI)
5.36%
3.3%
5.22%
6.7%
6.45%
7.72%
10.12%
Gross Profit Margin
11.92%
13.6%
13.0%
19.2%
15.02%
19.21%
17.52%
PAT Margin
4.92%
2.57%
2.44%
4.87%
7.81%
7.46%
7.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended May 2025 is 14.72% vs 16.16% in May 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended May 2025 is -25.66% vs 0.00% in May 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended May 2025 is 1.46% vs -12.82% in May 2024

stock-summary

Interest

YoY Growth in quarter ended May 2025 is 100.00% vs 1,800.00% in May 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended May 2025 has fallen from May 2024

Compare Quarterly Results Of Daito Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
14,034.00
0.00
14,034.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,034.00
0.00
14,034.00
Raw Material Cost
11,772.00
1.90
11,770.10
619,478.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
38.00
7.29
30.71
421.26%
Selling and Distribution Expenses
1,510.00
282.31
1,227.69
434.87%
Other Expenses
-3.80
71.58
-75.38
-105.31%
Total Expenditure (Excl Depreciation)
13,282.00
1,007.35
12,274.65
1,218.51%
Operating Profit (PBDIT) excl Other Income
752.00
-1,007.35
1,759.35
174.65%
Other Income
-1.00
-735.64
734.64
99.86%
Operating Profit (PBDIT)
1,875.00
-1,741.09
3,616.09
207.69%
Interest
38.00
7.29
30.71
421.26%
Exceptional Items
-164.00
0.00
-164.00
Gross Profit (PBDT)
2,262.00
-1.90
2,263.90
119,152.63%
Depreciation
1,124.00
1.90
1,122.10
59,057.89%
Profit Before Tax
549.00
-1,750.28
2,299.28
131.37%
Tax
-127.00
-218.79
91.79
41.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
691.00
-1,531.49
2,222.49
145.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
691.00
-1,531.49
2,222.49
145.12%
Share in Profit of Associates
0
0
0.00
Minority Interest
-16.00
0.00
-16.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
675.00
-1,531.49
2,206.49
144.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
52,003.00
1,895.02
50,107.98
2,644.19%
Earnings per share (EPS)
22.87
-21.38
44.25
206.97%
Diluted Earnings per share
22.87
-21.38
44.25
206.97%
Operating Profit Margin (Excl OI)
5.36%
0.00%
0.00
5.36%
Gross Profit Margin
11.92%
0.00%
0.00
11.92%
PAT Margin
4.92%
0.00%
0.00
4.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,403.40 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 17.87%

stock-summary

YoY Growth in quarter ended May 2025 is 14.72% vs 16.16% in May 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 67.50 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 180.08%

stock-summary

YoY Growth in quarter ended May 2025 is -25.66% vs 0.00% in May 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 187.60 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 11.47%

stock-summary

YoY Growth in quarter ended May 2025 is 1.46% vs -12.82% in May 2024

Quarterly - Interest
Interest 3.80 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 11.76%

stock-summary

YoY Growth in quarter ended May 2025 is 100.00% vs 1,800.00% in May 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.36%
in May 2025

Figures in %
stock-summary

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

stock-summary

YoY Growth in quarter ended May 2025 has fallen from May 2024